ANDY SASSINE - 15 Dec 2023 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Signature
/s/ Ilan Katz, attorney-in-fact
Issuer symbol
ARCT
Transactions as of
15 Dec 2023
Net transactions value
$0
Form type
4
Filing time
19 Dec 2023, 20:01:49 UTC
Previous filing
01 Nov 2023
Next filing
04 Jan 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Employee Stock Option (right to buy) Award $0 +75,000 $0.000000 75,000 15 Dec 2023 Common Stock 75,000 $28.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2 The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.